Thorsten Bischler - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Thorsten Bischler

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Brain, Behavior, and Immunity|January 15, 2022

Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease miceAkua A Karikari, Rhonda L McFleder, Eliana Ribechini, et al.

Experimental Hematology & Oncology|December 24, 2025

Efficacy of melflufen in multiple myeloma with mutated or deleted TP53Klara Acs, Juho J Miettinen, Philipp Sergeev, et al.

Hemasphere|July 12, 2024

Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myelomaLarissa Haertle, Umair Munawar, Hipólito N C Hernández, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Brain, Behavior, and Immunity|January 15, 2022

Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease miceAkua A Karikari, Rhonda L McFleder, Eliana Ribechini, et al.

Experimental Hematology & Oncology|December 24, 2025

Efficacy of melflufen in multiple myeloma with mutated or deleted TP53Klara Acs, Juho J Miettinen, Philipp Sergeev, et al.

Hemasphere|July 12, 2024

Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myelomaLarissa Haertle, Umair Munawar, Hipólito N C Hernández, et al.

Pageof 5